2002

Time to Let the Air Out If you think biotech stocks are headed for a breakout anytime soon, allow us […]

FDA rules need tweaking The biotech industry is suffering a mini-crisis of confidence that mirrors the larger shocks that have

deCODED? A new map of the human genome should help both doctors and biologists

Will R&D Make Merck Hot Again? The drug giant gets out of the prescription business and bets it all on

Will R&D Make Merck Hot Again? The drug giant gets out of the prescription business and bets it all on

Cracking the cancer code Whether a tumor invades the lung or breast is beside the point. Its genetic activity will

Report raps drug firms’ ‘post-approval’ studies Drug manufacturers spent $1.5 billion in 2000 to test medicines already approved by the

Report raps drug firms’ ‘post-approval’ studies Drug manufacturers spent $1.5 billion in 2000 to test medicines already approved by the

Of Clones and Clowns A distinguished molecular biologist discusses the “cloning circus” and the damage it is doing to serious

Legal Circumvention Molecular switches provide a route around existing gene patents